Juggernaut is one of those heroes in Dota 2 who can take over the entire game on his own. With his powerful early-game presence in the laning stage and impressive scaling potential into the late ...
When it comes to team fights, there are few heroes in Dota 2 that are as big of a threat to the enemy team as Dark Seer. This tanky hero is a master of controlling the flow of battle by providing ...
177Lu-DOTA-cG250 is administered as infusion through intravesical and intravenous route. Lutetium-177 labeled cG250 consisting of the chimeric monoclonal antibody girentuximab linked to the low energy ...
Dota 2 heroes are known for being talkative, constantly quipping with other heroes, and at your actions. With the Hero Chat Wheel, you gain access to some of your favorite hero’s most iconic lines.
177Lu-DOTA-cG250 is administered as infusion through intravesical and intravenous route. Lutetium-177 labeled cG250 consisting of the chimeric monoclonal antibody girentuximab linked to the low energy ...
MELBOURNE - Had it not been for Anna Kalinskaya's last-minute withdrawal at the Australian Open, Eva Lys would probably be on the road to her next tournament after losing in the third round of the ...
Sjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La). Anti-SS-A and anti-SS-B are ...
Eva Lys is officially a top-100 player for the first time in her career after rising 38 spots on this week's updated WTA rankings list and getting No. 91 in the world. At this past Australian Open ...
MELBOURNE - A ruthless Iga Swiatek slammed the door shut on German lucky loser Eva Lys with a 6-0 6-1 win on Monday to breeze into the quarter-finals of the year's opening Grand Slam for the ...
Add videos to your saved list and come back to them any time.
Harmful infectious organisms are identified as invaders due to their antigens (distinct molecules on their surface). Each antibody produced by your immune system binds to a specific antigen and then ...